Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
04-2007 | 01-2007 | 07-2006 | 04-2006 | |
Sales | 8 | 146 | 0 | 67 |
Gross Profit | 8 | 146 | N/A | 67 |
Operating Expenses | 1,533 | 1,339 | 689 | 1,055 |
Operating Income | -1,525 | -1,193 | -689 | -987 |
Interest Expense | 212 | 153 | 151 | 113 |
Other Income | -1,398 | 1,309 | 157 | -207 |
Pre-tax Income | -3,136 | -37 | -683 | -1,307 |
Net Income Continuous | -3,136 | -37 | -683 | -1,307 |
Net Income | $-3,136 | $-37 | $-683 | $-1,307 |
EPS Basic Total Ops | -0.07 | 0.00 | -0.02 | -0.03 |
EPS Basic Continuous Ops | -0.07 | 0.00 | -0.02 | -0.03 |
EPS Diluted Total Ops | -0.07 | 0.00 | -0.02 | -0.03 |
EPS Diluted Continuous Ops | -0.07 | 0.00 | -0.02 | -0.03 |
EBITDA(a) | $-1,451 | $-1,144 | $-651 | $-987 |